NEW YORK (GenomeWeb) – Interleukin Genetics reported today that its revenues for the second quarter were $376,051 compared to $528,595 in the year-ago period, marking a 29 percent decrease.

The company attributed the revenue decrease during the three months ended June 30 to fewer weight management genetic test kits returned for processing through Access Business Group's promotional bundle program.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.